Wanbury Ltd

WANBURY
NSE· Healthcare
₹344.75
+8.75 (+2.60%)
Updated 11:42 am IST
52W Low · ₹161.5052W High · ₹358.85
Near 52W High
Market Cap
₹916.46L Cr
Volume
22.08L
Prev Close
₹336.00
ISIN
INE107F01022

Orion Score

Fundamentals-based quality & risk · not a recommendation

35/100
Caution

Raw blend 51 capped to 35 by a red flag.

Why this is capped

Raw blend 51 → capped to 35

  • Low interest cover (0.5x) on real debt — distress risk
Quality
73
Growth
56
Safety
12
Value
30

Wanbury Ltd scores 35/100 (Caution) on the Orion Score — strong business quality (73), moderate growth (56), poor balance-sheet safety (12) and rich valuation (30). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Full Orion analysis

Risk checks

  • Low interest cover (0.5x) on real debt — distress risk

Forensic accounting

Piotroski F 3/9Altman Z Safe(4.19)Beneish M Elevated(-2.20)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

72/100

Strong

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION
No Data
D/E unavailable
QUALITY
High Quality
ROCE 29.2% — excellent capital efficiency
MOMENTUM
Bullish
RSI 77.0 — strong momentum

Price Chart

SMA 20
SMA 50
SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio
13.51
ROCE
29.20%
ROE (1Y)
76.50%
D/E Ratio
—
OPM
16.18%
TTM EPS
₹19.41
Dividend Yield
0.00%
Qtrly Sales
₹164.58 Cr
Qtrly Profit
₹21.70 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit
QuarterRevenueNet ProfitOPMEPS
Q4 2026₹164.58₹21.716.2%₹6.27
Q3 2026₹162.45₹15.7614.1%₹4.51
Q2 2026₹160.06₹15.1813.8%₹4.58
Q1 2026₹163.18₹13.4912.8%₹3.95
Q4 2025₹172₹20.2615.3%₹5.98

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit
YearRevenueNet ProfitEBITDAOPM
FY 2026₹650.27₹66.13₹104.0914.2%
FY 2025₹599.51₹30.53₹79.9110.5%
FY 2024₹574.48₹55.96₹98.5510.0%
FY 2023₹498.18₹-10.4₹23.492.4%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

CompanyMkt CapP/EROCEROED/EOPM
WANBURY ★₹916 Cr13.5129.20%76.50%—16.18%
SUNPHARMA₹4,27,609 Cr37.3215.73%14.72%0.06x18.90%
MAXHEALTH₹95,110 Cr66.2111.94%14.33%0.32x22.56%
AUROPHARMA₹90,029 Cr25.9412.55%9.93%0.21x15.11%
ABBOTINDIA₹57,724 Cr36.6336.14%34.46%0.04x27.01%
AJANTPHARM₹41,836 Cr39.5527.99%25.39%0.06x51.40%

Balance Sheet

All values in ₹ Crores

MetricFY 2025FY 2024FY 2023FY 2022
Total Assets₹413.92₹343.12₹303.52₹352.55
Equity₹59.27₹27.94₹-32.82₹-23.42
Total Debt₹176.91₹115.8₹108.58₹107.66
Cash₹4.06₹3.4₹1.49₹22.53
Net Debt₹169.17₹105.87₹102.96₹78.56
Working Capital₹18.83₹-52.09₹-196.24₹-186.57

Shareholding Pattern

Q3 FY2026

Promoter
43.08%
FII
0.72%
DII
—
Public
56.21%

Quarter-over-Quarter Trend

QuarterPromoterFIIDIIPublic
Q3 FY202643.08% ↓0.72% ↓—56.21% ↑
Q2 FY202643.09% ↑0.82% ↓—56.08% ↓
Q1 FY202639.63% ↓1.59% ↑—58.79% ↑
Q4 FY202539.76%1.55% ↑—58.68% ↓
Q3 FY202539.76% ↓0.84% ↓—59.4% ↑
Q2 FY202539.77% ↓1.02% ↑—59.21% ↓
Q1 FY202539.79%0.22% ↑—59.97% ↓
Q4 FY202439.79%0.18%—60.02%

Corporate Actions

No recent corporate actions

Funds Holding This Stock

1 mutual fund schemes

1
Bandhan BSE Healthcare Index Fund Direct GrowthIDFC

0.04%

₹0 Cr

Analyse WANBURY with Orion AI

Ask: "Is Wanbury Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Wanbury Ltd (WANBURY) Stock

Wanbury Ltd is listed on the NSE under the Healthcare sector, Pharmaceuticals industry. ISIN: INE107F01022. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.